HSA
VXRT

Hussman Strategic Advisors’s Vaxart VXRT Stock Holding History

Hussman Strategic Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200,000
Closed -$1.77M – 313
2020
Q2 		$1.77M Sell
200,000
-300,000
-60% -$862K 0.45% 92
2020
Q1 		$885K Buy
+500,000
New +$637K 0.24% 164

Other funds holding VXRT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hussman Strategic Advisors's VXRT Position: Q3 2020 in Review

Hussman Strategic Advisors sold out of Vaxart (VXRT) in Q3 2020, closing a stake of 200,000 shares — an estimated $1.77M sold.

Hussman Strategic Advisors first reported a position in VXRT in Q1 2020 and held it in 2 quarters. The position peaked at $1.77M in Q2 2020. 130 funds tracked by Wall St. Rank hold VXRT as of Q3 2020.

  • Hussman Strategic Advisors reported no remaining Vaxart position as of Q3 2020 after selling out during the quarter.
  • Hussman Strategic Advisors sold 200,000 Vaxart shares in Q3 2020, an estimated $1.77M.
  • Hussman Strategic Advisors first reported a position in Vaxart in Q1 2020 and held it in 2 quarters.
  • Hussman Strategic Advisors's Vaxart position peaked at $1.77M in Q2 2020.
  • 130 funds tracked by Wall St. Rank held Vaxart as of Q3 2020.

Based on Hussman Strategic Advisors's 13F filing for Q3 2020, filed 2 Nov 2020.